Reasons for participation in optional pharmacokinetic studies in children with cancer: A Children's Oncology Group Phase 1 Consortium study

Stacey L. Berg, Naomi Winick, Ashish Mark Ingle, Peter C. Adamson, Susan M. Blaney

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Fingerprint Dive into the research topics of 'Reasons for participation in optional pharmacokinetic studies in children with cancer: A Children's Oncology Group Phase 1 Consortium study'. Together they form a unique fingerprint.

Medicine & Life Sciences